PMVP PMV Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PMVP

Price (delayed)

$1.37

Market cap

$73.24M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.42

Enterprise value

$60.99M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 7
Highlights
The debt has dropped by 79% year-on-year and by 26% since the previous quarter
The EPS is up by 10% year-on-year and by 4.7% since the previous quarter
PMVP's equity is down by 49% year-on-year and by 19% since the previous quarter
The quick ratio is down by 39% YoY and by 31% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of PMVP

PMVP stock price

How has the PMV Pharmaceuticals stock price performed over time
Intraday
-9.27%
1 week
-4.2%
1 month
3.01%
1 year
-0.72%
YTD
9.6%
QTD
2.24%

Financial performance

How have PMV Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$79.66M
Net income
-$75.22M
Gross margin
N/A
Net margin
N/A
PMVP's operating income is up by 13% YoY and by 4.8% from the previous quarter
The company's net income rose by 7% YoY and by 4% QoQ

Price vs fundamentals

How does PMVP's price correlate with its fundamentals

Growth

What is PMV Pharmaceuticals's growth rate over time

Valuation

What is PMV Pharmaceuticals stock price valuation
P/E
N/A
P/B
1.02
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 10% year-on-year and by 4.7% since the previous quarter
PMVP's equity is down by 49% year-on-year and by 19% since the previous quarter
PMVP's price to book (P/B) is 41% more than its last 4 quarters average of 0.8 but 13% less than its 5-year quarterly average of 1.3

Efficiency

How efficient is PMV Pharmaceuticals business performance
PMV Pharmaceuticals's ROIC has plunged by 79% YoY and by 10% from the previous quarter
The company's return on equity has shrunk by 63% YoY and by 13% QoQ
The return on assets has dropped by 60% year-on-year and by 12% since the previous quarter

Dividends

What is PMVP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PMVP.

Financial health

How did PMV Pharmaceuticals financials performed over time
The total assets has declined by 46% year-on-year and by 15% since the previous quarter
The quick ratio is down by 39% YoY and by 31% QoQ
The debt is 100% smaller than the equity
The company's debt to equity has shrunk by 100% YoY
The debt has dropped by 79% year-on-year and by 26% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.